- Posts by Bradley Merrill ThompsonMember of the Firm
Attorney Brad Thompson counsels medical device, drug, and combination product companies on a wide range of FDA and FTC regulatory, reimbursement, and clinical trial issues.
Machine Learning and Artificial Intelligence Practice
Advances in artificial intelligence (“AI”) continue to present exciting opportunities to transform decision-making and targeted marketing within the world of consumer products. While AI has been touted for its capabilities in creating fairer, more inclusive systems, including with respect to lending and creditworthiness, AI models can also embed human and societal biases in a way that can result in unintended, and potentially unlawful, downstream effects.
Mostly when we talk about bias, we focus on accidental bias. What about intentional bias? The following ...
Blog Editors
Recent Updates
- Navigating Regulatory Challenges in the Dietary Supplement Industry: Insights on NJ Assembly Bill No. 1848
- Quashing an Out-of-State Subpoena: No Easy Task
- The Sleeping Giant: New York’s Commercial Division Expert Disclosure Rules
- Commission Commitments: Massachusetts Appeals Court Upholds Obligation to Continue Paying Commission for the Life of the Underlying Customer Relationship
- A Win for Out-of-Network Providers